Finasteride Tablet, Film Coated
Product Images NDC 68071-3380

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 68071-3380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 3380 3

Finasteride 5 mg film-coated tablets packaging label by NuCare Pharmaceuticals, Inc. The label shows a quantity of 30 tablets. It includes the NDC 68071-3380-3 and instructions to see the manufacturer's label for a full list of ingredients. The label also displays storage instructions to keep at controlled temperature 68-77°F and a warning to keep out of reach of children.*

FDA Label Image

Structure (Finasteride Fig 1)

Chemical structure of finasteride, showing its molecular framework with characteristic ring structures and functional groups relevant to its pharmaceutical composition.*

FDA Label Image

Image Of Figure 1 (Finasteride Fig 2)

A line graph showing mean change from baseline over four years comparing Finasteride to placebo. The y-axis represents mean change with standard error, ranging from 0 to -6. The x-axis shows time points: baseline, year 1, year 2, year 3, and year 4. Finasteride shows a steady decrease from baseline over the years, whereas placebo remains near baseline. Sample sizes for each time point are noted below the x-axis.*

FDA Label Image

Image Of Figure 2 (Finasteride Fig 3)

A line graph comparing cumulative events over 48 months between Finasteride and Placebo groups, with percent of patients on the y-axis and observation time in months on the x-axis. Below the graph, tables provide the number of events and patients at risk per year for each group.*

FDA Label Image

Image Of Figure 3 (Finasteride Fig 4)

A line graph showing the mean percent change from baseline over four years with standard error bars. It compares results for two groups: one receiving placebo and the other Finasteride, with data points plotted annually from baseline to year 4, including sample sizes at each interval.*

FDA Label Image

Image Of Figure 4 (Finasteride Fig 5)

A line graph depicting the percent with event over years from randomization, comparing four groups: Placebo, Finasteride, Doxazosin, and Combination. The y-axis shows percent with event from 0 to 25, and the x-axis shows years from 0.0 to 5.5. The Placebo group shows the highest event rate, followed by Finasteride, Doxazosin, and the Combination group with the lowest event rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.